At a glance
ClinicalIndex Comparison RecordN/ACompleted· 480 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation: a Case-control Study
In Brief
An observational study for Schizophrenia. Completed, enrolled 480 participants across 1 site.
Detailed Summary
Study objectives: 1. Describe the characteristics of discharged patients with schizophrenia achieving functional remission after drug discontinuation. 2. Establish a prediction model of patients with schizophrenia having good prognosis after drug discontinuation.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesChina
CollaboratorsMerck Sharp & Dohme LLC
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartSep 2022
First PostedDec 2022
Primary CompletionJan 2025
Study CompletionMar 2025
TodayJul 2026
First PostedDec 29, 2022
Enrollment StartSep 15, 2022
Primary CompletionJan 31, 2025
Study CompletionMar 31, 2025
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 3.5 years ago